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Preeclampsia is associated with compromised maternal synthesis of long-chain 
polyunsaturated fatty acids, leading to offspring deficiency 
Abstract 
Obesity and excessive lipolysis are implicated in preeclampsia (PE). Intrauterine growth restriction is 
associated with low maternal body mass index and decreased lipolysis. Our aim was to assess how 
maternal and offspring fatty acid metabolism is altered in mothers in the third trimester of pregnancy with 
PE (n=62) or intrauterine growth restriction (n=23) compared with healthy pregnancies (n=164). Markers 
of lipid metabolism and erythrocyte fatty acid concentrations were measured. Maternal adipose tissue 
fatty acid composition and mRNA expression of adipose tissue fatty acid–metabolizing enzymes and 
placental fatty acid transporters were compared. Mothers with PE had higher plasma triglyceride (21%, 
P<0.001) and nonesterified fatty acid (50%, P<0.001) concentrations than controls. Concentrations of 
major n−6 and n−3 long-chain polyunsaturated fatty acids in erythrocytes were 23% to 60% lower (all 
P<0.005) in PE and intrauterine growth restriction mothers and offspring compared with controls. 
Subcutaneous adipose tissue −5 and −6 desaturase and very long-chain fatty acid elongase mRNA 
expression was lower in PE than controls (respectively, mean [SD] control 3.38 [2.96] versus PE 1.83 
[1.91], P=0.030; 3.33 [2.25] versus 1.03 [0.96], P<0.001; 0.40 [0.81] versus 0.00 [0.00], P=0.038 expression 
relative to control gene [square root]). Low maternal and fetal long-chain polyunsaturated fatty acid 
concentrations in PE may be the result of decreased maternal synthesis. 
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Preeclampsia
Preeclampsia (PE), a multisystem disorder particular to preg-nancy, is a leading cause of maternal and neonatal morbid-
ity and mortality. PE is characterized by widespread endothelial 
dysfunction, resulting in hypertension attributable to vasocon-
striction, proteinuria attributable to glomerular damage, and 
edema secondary to increased vascular permeability. Maternal 
obesity, increased insulin resistance, and aberrant fatty acid 
metabolism are involved in its pathogenesis.1 Excessive non-
esterified fatty acid (NEFA) flux in PE, similar to that seen 
in nonalcoholic fatty liver disease, may instigate ectopic lipid 
accumulation in the liver and other tissues2 and interfere with 
long-chain polyunsaturated fatty acid (LC PUFA) synthesis.3 
Intrauterine growth restriction (IUGR) can occur independently 
or simultaneously with PE. Isolated IUGR pregnancies are char-
acterized by low maternal body mass index (BMI), low plasma 
lipid levels, and reduced lipolysis.4,5 Few data exist on the 
impact of PE or IUGR on maternal fatty acid mobilization dur-
ing pregnancy, and those available have focused on percentage 
of total fatty acids in plasma6–9 rather than absolute amounts or 
erythrocyte composition. These latter measures allow primary 
independent effects on individual fatty acids to be determined 
and better reflect tissue fatty acid composition and long-term 
nutritional status rather than recent dietary intake.10
LC PUFAs of the n−3 and n−6 series, such as docosahexae-
noic acid (22:6n−3) and arachidonic acid (20:4n−6), are 
required for fetal growth11 and brain development.12 Thus, 
a potential long-term consequence of disturbed LC PUFA 
synthesis in PE is suboptimal neurodevelopment of the infants.13 
Maternal LC PUFAs are mobilized by week 13 of gestation,14 
but their source(s) are not established. The n−6 and n−3 LC 
PUFAs are synthesized from essential shorter chain precur-
sors (18:2n−6 and 18:3n−3, respectively) via Δ5-desaturase, 
Δ6-desaturase, and elongase enzymes (Figure S1 in the online-
only Data Supplement). Pregnant women accumulate adipose 
tissue in the early anabolic stage of pregnancy, but in later 
gestations, because of insulin resistance, adipose tissue fatty 
acid mobilization increases.15 Placental transfer of LC PUFAs 
to the fetus is obligatory,12 and both circulating NEFAs and 
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fatty acids released from lipolysis of lipoprotein triglycerides 
are transported across the placenta by a series of fatty acid–
binding and transfer proteins.16 Among these, placental plasma 
membrane-associated fatty acid binding protein (pFABPpm), a 
membrane transporter, and fatty acid binding protein (FABP)7, 
an intracellular transporter, have high affinities for 22:6n−3 
and are expressed by trophoblasts.17–19
We hypothesized that, in an analogous way to nonalcoholic 
fatty liver disease, excessive NEFA flux in PE provokes ectopic 
lipid accumulation in the liver and inhibits LC PUFA synthesis. 
Our aim was to assess whether maternal fatty acid metabolism 
is altered in mothers with PE or IUGR compared with healthy 
pregnancy and impacts on offspring LC PUFA status. We car-
ried out erythrocyte fatty acid compositional analysis of paired 
maternal and fetal samples from healthy and complicated 
pregnancies. Markers of lipid metabolism were also assessed 
to describe the gross differences in fuel metabolism. To assess 
whether LC PUFA status was related to the composition of 
stored fatty acids we analyzed both visceral and upper body 
subcutaneous adipose tissue fatty acid composition in a subset 
of the pregnancies. The mRNA expression of desaturase and 
elongase enzymes was quantitated in adipose tissue as a marker 
of LC PUFA synthesis in this and other tissues. To test whether 
offspring LC PUFA status was related to placental transfer of 
fatty acids, mRNA expression of key enzymes and transporters 
in LC PUFA metabolism was quantitated in placental biopsies.
Methods
Subjects
Subjects with PE (n=62), subjects with IUGR (n=23), and controls 
with uncomplicated pregnancies (n=164) in the third trimester of a 
singleton pregnancy were recruited. The study was approved by the 
Glasgow Royal Infirmary Local Research Ethics Committee, and 
women gave written informed consent. For further details on recruit-
ment and biopsy sampling please see the online-only Data Supplement.
Biochemical Analyses
Total cholesterol, triglyceride and high-density lipoprotein choles-
terol assays,20 and glucose and high-sensitivity C-reactive protein 
assays21 were performed at the Department of Clinical Biochemistry, 
Glasgow Royal Infirmary. Other analytes were assayed using com-
mercially available kits (please see the online-only Data Supplement). 
Fatty acids were extracted from erythrocyte membranes14 and adipose 
tissue and identified by gas chromatography14,22 (for details please see 
online-only Data Supplement).
Messenger RNA Expression
Total RNA was isolated from placenta (control n=57, PE n=17, and 
IUGR n=11), subcutaneous adipose tissue (control n=50, PE n=12, 
and IUGR n=13), and visceral adipose tissue (control n=25, PE n=12 
and IUGR n=5) and cDNA was synthesized. Target gene expression 
was quantitated relative to a control gene by TaqMan real-time poly-
merase chain reaction using commercial primer probe sets (Applied 
Biosystems; for details please see the online-only Data Supplement).
Statistical Analysis
Details of statistical analysis are provided in the online-only Data 
Supplement. Unsaturation index is the average number of dou-
ble bonds per fatty acid residue multiplied by 100; average chain 
length is the sum of mol% times chain length for each reported fatty 
acid divided by 100; C20–22 is the total percentage of LC PUFAs 
with ≥20 carbon units; docosahexaenoic acid deficiency index is 
22:5n−6/22:4n−6; and essential fatty acid (EFA) deficiency index 
is (n−3+n−6)/(n−7+n−9). Because of multiple testing, significance 
 levels were set at P<0.005 for plasma metabolic markers and fatty 
acid analysis.
Results
Maternal Metabolic and Inflammatory Profile
Maternal antenatal booking characteristics (please see Table 
S1 in the online-only Data Supplement) and third-trimester 
plasma profiles (please see Table S2) are shown. Mothers with 
PE had higher levels of triglyceride, NEFA, leptin, adiponec-
tin, and interleukin 6 than controls, and these differences were 
maintained after adjustment for maternal BMI, parity, smok-
ing status, and gestational age at sampling.
Impact of PE and IUGR on  
Maternal LC PUFA Status
Maternal third-trimester erythrocyte fatty acid concentra-
tions are shown in Table 1. There were no differences in 
concentrations of saturated fatty acids (SAFAs) between 
groups apart from a lower concentration of the minor fatty 
acid 22:0 in IUGR. For the monounsaturated fatty acids, 
there was a 19% lower concentration of 24:1n−9 in IUGR. 
Concentrations of all n−6 PUFAs, apart from the minor fatty 
acids 18:3n−6 and 22:2n−6, were 23% to 60% lower in both 
PE and IUGR mothers. Of the n−3 PUFAs, 22:5n−3 and 
22:6n−3 were lower in PE and IUGR mothers to a similar 
extent as for the n−6 PUFAs. Interestingly, 20:5n−3 was not 
different between groups.
Summary indices of maternal fatty acid status are shown 
in Table 1. The percentage of SAFAs is higher and the per-
centage of unsaturated fatty acids and PUFAs is significantly 
lower in PE and IUGR. The main driver for the change in 
proportions is the lower PUFAs, because concentrations of 
SAFAs are similar between groups. The lower PUFA concen-
trations account for the lower unsaturation index and average 
chain length observed in PE and IUGR. Because concentra-
tions of both n−6 and n−3 PUFAs are lower, the n−6/n−3 ratio 
is similar across groups. PE and IUGR mothers are deficient 
in EFAs and 22:6n−3. All observed differences were main-
tained after adjustment for potential confounders. Women 
with severe PE had significantly lower concentrations than 
those with mild PE for the majority of fatty acid parameters 
measured (please see Table S3). There was no relationship 
with gestational age at PE onset (data not shown).
Offspring Metabolic and Inflammatory Profile
Cord blood total cholesterol, but not high-density lipoprotein, 
concentration was significantly higher in PE offspring 
(please see Table S2). Conversely, both total and high-density 
lipoprotein cholesterol concentrations were lower in IUGR 
compared with control offspring. Cord blood triglyceride 
concentrations were higher in PE and IUGR offspring 
compared with controls. There were no differences in cord 
blood NEFA, glucose, insulin, insulin resistance (homeostatic 
model assessment), or inflammatory marker levels between 
groups. Cord blood leptin (46%–68%) and adiponectin 
(38%–60%) levels were significantly lower in PE and IUGR 
offspring, associations that were lost after adjusting for 
maternal BMI and gestation at delivery for leptin and maternal 
smoking for adiponectin, as described by others.23–25
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Table 1. Maternal Erythrocyte Fatty Acid Concentrations (nmol/mL of Blood) From Third-Trimester Control, PE, and IUGR Mothers
Fatty Acid Control (n=164) PE (n=62) IUGR (n=23) P* Adjusted P†
SAFA
 12:0 0.3 (2) 1.4 (5) 0 (0) 0.026 0.099
 14:0 15 (9) 17 (8) 16 (8) 0.26 0.48
 16:0 516 (116) 531 (107) 447 (128) 0.010 0.016
 17:0 6 (5) 5 (5) 7 (4) 0.21 0.19
 18:0 318 (74) 294 (70) 294 (83) 0.055 0.021
 20:0 11 (4) 10 (4) 11 (4) 0.65 0.11
 22:0 22 (14)a 17 (16)a 9 (12)b <0.001 <0.001
 24:0 60 (12) 61 (17) 61 (13) 0.80 0.85
MUFA
 14:1n−7 0 (0) 0 (0) 0 (0) - -
 16:1n−7 17 (10) 20 (9) 17 (10) 0.20 0.079
 17:1n−7 17 (28) 15 (27) 15 (27) 0.81 0.69
 18:1n−7 5 (10) 5 (11) 3 (9) 0.71 0.96
 18:1n−9 288 (80) 283 (65) 238 (71) 0.012 0.007
 20:1n−9 8 (5) 6 (5) 6 (4) 0.025 0.007
 22:1n−9 1 (3) 1 (3) 0 (0) 0.21 0.11
 24:1n−9 86 (22)a 80 (20)a,b 70 (21)b 0.002 0.004
PUFA n−6
 18:2n−6 171 (54)a 130 (51)b 115 (49)b <0.001 <0.001
 18:3n−6 1.8 (3) 1.3 (3) 2.1 (3) 0.43 0.38
 20:2n−6 4 (5)a 2 (3)b 2 (3)b <0.001 <0.001
 20:3n−6 32 (15)a 23 (14)b 20 (11)b <0.001 <0.001
 20:4n−6 225 (89)a 142 (97)b 128 (82)b <0.001 <0.001
 22:2n−6 0.8 (1.8) 0.7 (1.5) 0.8 (1.6) 0.97 0.64
 22:4n−6 43 (20)a 26 (20)b 25 (17)b <0.001 <0.001
 22:5n−6 10 (6)a 5 (6)b 4 (5)b <0.001 <0.001
PUFA n−3
 18:3n−3 5 (4) 3 (3) 4 (3) 0.028 <0.001
 20:3n−3 1.1 (2.8) 0.1 (0.6) 0 (0) 0.006 0.002
 20:5n−3 16 (10) 16 (10) 17 (12) 0.91 0.86
 22:3n−3 3.6 (5.1) 2.6 (4.0) 1.5 (2.3) 0.080 0.012
 22:5n−3 32 (14)a 19 (14)b 17 (14)b <0.001 <0.001
 22:6n−3 65 (30)a 40 (35)b 39 (31)b <0.001 <0.001
Summary indices
 % SAFA 49 (7)a 54 (9)b 56 (10)b <0.001 <0.001
 % MUFA 21 (2)a 23 (2)b 22 (4)a <0.001 <0.001
 % PUFA 30 (7)a 22 (9)b 22 (9)b <0.001 <0.001
 % UNSAT 51 (7)a 46 (9)b 44 (10)b <0.001 <0.001
 Unsaturation index 131 (29)a 102 (35)b 101 (36)b <0.001 <0.001
 Average chain length 18.5 (0.3)a 18.3 (0.3)b 18.3 (0.3)b <0.001 <0.001
 C 20–22 26 (6)a 20 (7)b 21 (6)b <0.001 <0.001
 n−6/n−3 ratio 4.2 (1.2) 4.5 (2.0) 4.5 (2.1) 0.21 0.21
 DHA deficiency index 0.20 (0.11)a 0.13 (0.16)b 0.11 (0.11)b <0.001 <0.001
 EFA deficiency index 1.44 (0.39)a 0.98 (0.42)b 1.02 (0.41)b <0.001 <0.001
PE indicates preeclampsia; IUGR, intrauterine growth restriction; SAFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; UNSAT, 
unsaturated fatty acid; DHA, docosahexaenoic acid; EFA, essential fatty acid; BMI, body mass index.
Values are mean (SD).
*ANOVA was used to test for differences among groups. Different superscript letters indicate differences between individual groups using post hoc Tukey test. Significance 
level P<0.005.
†Adjusted for maternal BMI, parity, smoking status, and gestational age at sampling.
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Impact of PE and IUGR on  
Offspring LC PUFA Status
Cord blood erythrocyte SAFA concentrations were similar 
between groups apart from higher levels of the minor fatty 
acids 14:0 and 17:0 in PE and IUGR (Table 2). There were 
no differences in monounsaturated fatty acid concentrations 
between groups. There were significantly lower 20:3n−6, 
22:4n−6, and 22:5n−6 concentrations in PE and IUGR, and 
there was a trend toward reduced 20:4n−6. Similar to their 
mothers, there were significantly lower concentrations of 
22:5n−3 and 22:6n−3 in PE and IUGR offspring. The lower 
22:5n−3 concentration was lost on adjustment for confound-
ers, particularly parity. Interestingly, there was a trend toward 
higher 18:3n−3 concentration in PE and IUGR.
Summary measures for cord blood erythrocytes are shown in 
Table 2. The pattern in cord blood is the same as that observed 
in their mothers, that is, a higher proportion of SAFAs and 
a reduced proportion of unsaturated fatty acids and PUFAs, 
driven by the lower levels of PUFAs. PE offspring had lower 
22:6n−3 and were classed as being EFA deficient, whereas in 
IUGR offspring there was only a trend toward a deficiency in 
22:6n−3 and EFAs. The study was underpowered to examine 
the impact of severity of PE on offspring fatty acid composi-
tion. Figure 1 shows percentage of maternal and cord blood 
PUFA concentrations relative to the control concentration for 
PE (Figure 1A) and IUGR (Figure 1B). Values <100% indi-
cate a relative fatty acid deficiency compared with controls. 
IUGR and PE maternal fatty acids levels are all deficient apart 
from 20:5n−3. Cord blood levels of PUFAs were deficient to 
a lesser degree than mothers. For the majority of PUFAs, the 
relative deficiency in the IUGR offspring is less than that in 
PE, but this did not reach statistical significance because of 
high interindividual variability.
Maternal Adipose Tissue as a Potential  
Source of LC PUFAs
There were no differences in subcutaneous or visceral adipose 
tissue fatty acid composition among controls, PE mothers, 
and IUGR mothers (please see Tables S4 and S5). The pre-
dominant fatty acids in both tissues were 16:0, 18:1n−9, and 
18:2n−6. LC PUFA was a minor component of adipose tissue. 
There were significant differences in subcutaneous adipose 
tissue Δ5-desaturase (FADS1) and Δ6-desaturase (FADS2) 
mRNA expression between groups (Figure 2A). Subcutaneous 
adipose tissue FADS1 and FADS2 expression in PE was lower 
than in controls (mean [SD], control 3.38 [2.96] versus PE 
1.83 [1.91] square root FADS1 expression relative to PPIA, 
P=0.030 and control 3.33 [2.25] versus PE 1.03 [0.96] square 
root FADS2 expression relative to PPIA, P<0.001 respec-
tively. All PE subcutaneous adipose tissue samples showed no 
detectable expression of subcutaneous very long-chain fatty 
acid elongase (ELOVL2). There was a significantly higher 
proportion of detectable subcutaneous adipose tissue ELOVL2 
expression in control compared with PE (P=0.038). There 
were no significant differences in FADS1, FADS2, or ELOVL2 
mRNA expression in visceral adipose tissue (Figure 2B). 
Stearoyl CoA desaturase and long-chain fatty acid elongase 
(ELOVL6) mRNA expression did not differ among groups in 
either subcutaneous or visceral adipose tissues.
Placental Fatty Acid Metabolism and  
Transport Markers
To confirm whether low cord levels of 20:3n−6 in the presence 
of normal levels of 18:2n−6 was indicative of low Δ6-desaturase 
activity in PE and IUGR offspring, Δ6-desaturase (FADS2) 
mRNA expression in a fetal tissue (placenta) was quantitated 
and found not to be different among groups (Figure 2C). 
To test whether lower offspring LC PUFA levels 
might be attributed to lower placental expression of fatty acid 
transfer proteins, mRNA expression of placental fatty acid 
transporters (pFABPpm [GOT2] and FABP7) was assessed 
and found not to differ among groups (Figure 2C). The lack 
of difference in placental gene expression was independent of 
the mode of delivery.
Discussion
Absolute amounts of maternal erythrocyte n−6 and n−3 PUFA 
concentrations were ≈60% lower in PE and IUGR compared 
with controls, and cord blood LC PUFA deficiency is also com-
mon to PE and IUGR. Low amounts of maternal LC PUFAs 
could result from inhibition of synthesis, decreased release 
from maternal stores, or reduced acquisition from diet.
In PE, the metabolic pattern is of high BMI and high plasma 
triglyceride and NEFA concentrations. Although we could 
not assess maternal insulin resistance because of the random 
nature of maternal blood samples, second-trimester insulin 
resistance has previously been shown to be associated with 
PE.26 The complete biochemical profile of PE women observed 
here is indicative of metabolic syndrome, a biochemical 
manifestation of insulin resistance that is typical of PE.27 The 
observed reduced adipose tissue Δ5- and Δ6-desaturase and 
ELOVL2 expression (please see Figure S2 in the online-only 
Data Supplement) suggests that low LC PUFAs in PE could 
be attributable to decreased synthesis. We have previously 
hypothesized that increased NEFA flux in pregnancy can lead 
to mitochondrial dysfunction,2 thus impairing LC PUFA syn-
thesis, analogous to the situation in nonalcoholic fatty liver 
disease, which is associated with obesity, insulin resistance, 
and ectopic lipid accumulation in the liver. In nonalcoholic 
fatty liver disease, LC PUFAs in liver are depleted possibly 
via reduced Δ5- and Δ6-desaturase activities.3 It was notable 
that the magnitude of reduction in LC PUFAs was greater in 
women with severe PE.
Mothers with IUGR are reported to have low lipolysis 
rates4 and low BMI.28 In IUGR, we observed trends toward 
lower maternal erythrocyte concentrations of the major fatty 
acids stored in adipose tissue, 18:1n−9 and 16:0,29 which are 
consistent with lower adipocyte lipolysis. The metabolic pat-
tern in IUGR mothers thus may indicate a primary defect in 
fat storage and mobilization from adipose tissue (please see 
Figure S2). IUGR cord leptin levels are extremely low, reflect-
ing reduced adipose tissue depots; however, the level of cord 
triglyceride is high and the concentration of NEFA is normal, 
suggesting that, although maternal fatty acid supply may be 
abnormal, there is still fetal capacity for triglyceride synthesis.
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Table 2. Cord Erythrocyte Fatty Acid Concentrations (nmol/mL of Blood) From Control, PE, and IUGR Offspring
Fatty Acid Control (n=85) PE (n=21) IUGR (n=13) P* Adjusted P†
SAFA
 12:0 0 (0) 0 (0) 0 (0) - -
 14:0 8 (4)a 11 (5)b 12 (5)b 0.001 0.044
 16:0 429 (99) 446 (78) 451 (90) 0.60 0.81
 17:0 3 (2)a 4 (2)a,b 5 (1)b <0.001 0.045
 18:0 275 (59) 265 (43) 272 (35) 0.74 0.86
 20:0 8 (3) 8 (3) 7 (2) 0.20 0.18
 22:0 21 (7) 19 (4) 17 (5) 0.08 0.044
 24:0 62 (14) 59 (9) 57 (9) 0.31 0.078
MUFA
 14:1n−7 1.0 (3.8) 1.0 (2.2) 1.5 (3.5) 0.87 0.82
 16:1n−7 10 (6) 10 (5) 8 (2) 0.34 0.53
 17:1n−7 29 (24) 38 (21) 45 (16) 0.023 0.14
 18:1n−7 14 (16) 9 (14) 5 (13) 0.13 0.47
 18:1n−9 171 (54) 168 (38) 163 (33) 0.88 0.82
 20:1n−9 1.5 (1.6) 2.4 (2.6) 2.3 (1.2) 0.087 0.85
 22:1n−9 0.2 (1.1) 0 (0) 0 (0) 0.71 0.38
 24:1n−9 57 (16) 57 (15) 56 (11) 0.97 0.73
PUFA n−6
 18:2n−6 57 (18) 55(16) 57 (17) 0.91 0.67
 18:3n−6 0.4 (1.1) 0.6 (0.8) 0.9 (1.2) 0.22 0.26
 20:2n−6 5 (6) 4 (6) 5 (4) 0.76 0.094
 20:3n−6 41 (16)a 30 (15)b 27 (11)b 0.002 0.016
 20:4n−6 239 (90) 176 (90) 193 (66) 0.007 0.008
 22:2n−6 1.9 (3.6) 0.4 (1.9) 0 (0) 0.037 0.055
 22:4n−6 48 (19)a 33 (18)b 37 (13)a,b 0.002 0.016
 22:5n−6 18 (8)a 10 (7)b 12 (5)b <0.001 0.006
PUFA n−3
 18:3n−3 0.08 (0.3) 0.39 (0.8) 0.37 (0.6) 0.011 0.087
 20:5n−3 6.1 (7) 5.0 (8) 2.6 (4) 0.22 0.52
 22:3n−3 0.1 (0.4) 0 (0) 0 (0) 0.67 0.16
 22:5n−3 11 (5)a 7 (6)b 8 (5)a,b 0.004 0.11
 22:6n−3 73 (33)a 49 (31)b 53 (29)a,b 0.003 0.03
Summary Indices
 % SAFA 51 (7) 56 (10) 55 (9) 0.007 0.007
 % MUFA 18 (2)a 19 (4)b 19 (2)a,b 0.002 0.094
 % PUFA 31 (7)a 24 (9)b 26 (9)a,b <0.001 0.002
 % UNSAT 49 (7) 44 (10) 45 (9) 0.007 0.007
 Unsaturation index 141 (29)a 114 (36)b 122 (35)a,b <0.001 0.003
 Average chain length 18.7 (0.3)a 18.4 (0.3)b 18.4 (0.3)b <0.001 <0.001
 C 20–22 33 (6.2)a 27 (6.4)b 28 (6.9)b <0.001 <0.001
 n−6/n−3 ratio 4.8 (1.2) 5.1 (2.1) 5.1 (2.0) 0.63 0.98
 DHA deficiency index 0.36 (0.10) 0.30 (0.12) 0.32 (0.08) 0.019 0.13
 EFA deficiency index 1.84 (0.53)a 1.33 (0.55)b 1.48 (0.39)a,b <0.001 0.001
PE indicates preeclampsia; IUGR, intrauterine growth restriction; SAFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; 
UNSAT, unsaturated fatty acid; DHA, docosahexaenoic acid; EFA, essential fatty acid; BMI, body mass index.
Values are mean (SD).
*ANOVA was used to test for differences among groups. Different superscript letters indicate differences between individual groups using post hoc Tukey test.  
Significance level P<0.005.
†Adjusted for maternal BMI, parity, smoking status, and gestational age at delivery.
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The ratio of the n−6: n−3 series remains similar among 
groups, suggesting that both pathways are affected equally. 
It is notable that PE and IUGR mothers are not deficient in 
20:5n−3, which suggests that it can be synthesized from 
18:3n−3. Elongation or desaturation pathways downstream of 
this point may be impaired (please see Figures S1 and S2). We 
observed that subcutaneous adipose tissue mRNA expression 
of Δ5- and Δ6-desaturase and very long-chain fatty acid elon-
gase (ELOVL2, which acts on C20 and C22 fatty acids) was 
significantly lower in PE mothers, suggesting compromized 
synthesis downstream of C20. Adipose tissue is not a major 
site of LC PUFA synthesis, but expression here may reflect 
the expression of synthetic enzymes in inaccessible tissues, 
for example, the liver.
It is not known from which maternal stores LC PUFAs are 
mobilized in pregnancy. Potential sites are adipose tissue, liver, 
and membranes (including the brain). As in the nonpregnant 
state,29 maternal adipose tissue contains reasonable quantities 
of 18:2n−6, but very little 18:3n−3 and minor amounts of LC 
PUFAs. There were also no differences in adipose tissue fatty 
acid composition between groups that could explain the large 
difference in maternal erythrocyte LC PUFA concentrations. 
Together, these data suggest that maternal adipose tissue does 
not act as a short-term store or site of synthesis of PUFAs. It is 
possible that maternal membrane (brain) and liver LC PUFA 
stores are affected in PE and IUGR, especially if synthetic 
pathways are impeded.
Differing diet between PE and IUGR mothers and con-
trols is another potential explanation for reduced PUFAs. The 
extent of deficiency (≤ 60%) would suggest that diets would 
have to be substantially different to have that magnitude of 
effect on erythrocyte PUFA concentrations. Vegan mothers 
are not specifically susceptible to PE or IUGR30,31 nor do they 
demonstrate a similar degree of EFA deficiency.32 In our study, 
the ratio of 22:5n−6/22:6n−3, a measure of dietary ω-3 or 
22:6n−3 deficiency,33 was not significantly different between 
PE cases and controls, further suggesting that diet alone is not 
the cause of the fatty acid changes. There is also no evidence 
that dietary supplementation with LC PUFAs impacts on inci-
dence of PE or IUGR.34,35
The fetus is dependent on the mother for its EFA supply; 
therefore, it is not surprising that we observed reduced LC 
PUFAs in PE and IUGR offspring. The degree to which the 
infants are deficient is less than that expected from the lack of 
mobilization in the mothers (Figure 1). Docosahexaenoic acid 
is an extremely important fatty acid for fetal neural develop-
ment, and PE cord blood erythrocytes have a lesser degree of 
docosahexaenoic acid deficiency than EFA deficiency (Table 2). 
This suggests that there are mechanisms to compensate, 
such as upregulation of placental transport or fetal synthesis. 
There was no difference in placental expression of pFABPpm 
(GOT2) and FABP7 between groups. However, there is a wide 
array of placental fatty acid transport proteins,16 and a more 
systematic analysis is required to eliminate the possibility 
of upregulation of placental fatty acid transport. There was a 
trend toward increased levels of 18:3n−3, the precursor of n−3 
PUFAs in cord erythrocytes for PE and IUGR. However, pla-
cental 6-desaturase mRNA expression did not differ. Thus, 
there is no evidence for upregulation of placental or fetal fatty 
acid synthesis pathways. Both PE and IUGR offspring had 
significantly lower cord blood adiponectin levels than controls 
(please see Table S2), which may result from reduced n−3 LC 
PUFA-induced adiponectin release from adipocytes.36,37
The strength of our data is the use of absolute fatty acid 
concentrations, which allows us to understand which specific 
fatty acids are driving the differences in composition between 
healthy and complicated pregnancies. There are limitations to 
our study. Blood samples were random, and women were not 
all fasted, which will have an impact on some maternal vari-
ables (triglyceride and NEFA levels) but not erythrocyte fatty 
acid composition. No samples from prepregnancy or early 
gestation were available for these women. There were few 
IUGR subjects; the PE group was a mixture of primiparous 
and parous women with potentially different underlying risk 
factors, and there were no dietary intake data.
Perspectives
At birth, the offspring of PE and IUGR pregnancies are defi-
cient in essential LC PUFAs, which may have long-term 
consequences for their development. The mechanisms by 
which these deficiencies arise differ between PE and IUGR 
and suggest different interventions. In IUGR, LC PUFA sup-
plementation may overcome the lack of maternal fatty acid 
mobilization. In PE, insulin-sensitizing treatments such as 
metformin may reduce ectopic fat accumulation and upregu-





















































18:2n-6  20:4n-6 20:3n-6  22:4n-6  22:5n-6 20:5n-3  22:5n-3  22:6n-3
Figure 1. Maternal (◼) and cord ( □ ) plasma polyunsaturated fatty acid (PUFA) concentration expressed as a percentage of control 
maternal and cord fatty acid concentration, respectively, in pregnancies complicated by (A) preeclampsia and (B) intrauterine growth 
restriction (IUGR).
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Figure 2. A, Maternal subcutaneous adipose tissue gene 
expression in control (n=50), preeclampsia (PE) (n=12), and 
intrauterine growth restriction (IUGR) (n=13). B, Maternal visceral 
adipose tissue gene expression in control (n=25), PE (n=12), 
and IUGR (n=5). C, Placental gene expression in control (n=57), 
PE (n=17), and IUGR (n=11) pregnancy relative to control gene 
(PPIA for adipose tissue and TOP1 for placenta). Means (SEs) of 
transformed (log[GOT2 and FADS2] or square root [sqrt]) target 
gene expression relative to control gene expression values are 
presented. *Significant difference among groups on ANOVA; 
#Significant difference among groups on Kruskal–Wallis test.
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What Is New?
 This study shows that levels of a class of fats that are particularly 
important for fetal brain development (long-chain polyunsaturated 
fatty acids) are lower in maternal and cord blood in pregnancies 
complicated by preeclampsia and intrauterine growth restriction. We 
provide evidence that in preeclampsia this might be attributable to 
a decreased ability of the mother to make these fats from dietary 
precursors.
What Is Relevant?
 The findings are important because they indicate that offspring of preg-
nancies complicated by preeclampsia or intrauterine growth restriction 
may be at risk of impaired neural development and suggest that the ap-
proaches to reducing this risk would differ. In preeclampsia, drug inter-
ventions that may improve the mother’s metabolism and ability to make 
long-chain polyunsaturated fatty acids are indicated, whereas in intra-
uterine growth restriction, supplementation of the diet with long-chain 
polyunsaturated fatty acids would be indicated.
Summary
Low maternal and offspring levels of fats important for offspring 
neural development in preeclampsia may be attributable to an im-
paired ability of the mother to synthesize them.
Novelty and Significance
